VisionCare Ophthalmic Technologies

Bookmark

Add to MyYahoo RSS

VisionCare Ophthalmic Technologies News

News on VisionCare Ophthalmic Technologies (Ticker: JNJ) continually updated from thousands of sources around the net.

Tuesday | Insider Monkey

Apple Inc. (AAPL), American Express Company (AXP), Johnson & Johnson...

Ken Fisher 's Fisher Asset Management filed a few weeks ago its Form 13F for the second quarter of 2014.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Apple, Startups, Financial Services, Travelers Express Company

Mon Aug 18, 2014

The Motley Fool

3 Reasons Johnson & Johnson Stock Could Rise

For the quarter, Johnson & Johnson delivered impressive revenue growth of 9.1% year-over-year.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Sun Aug 17, 2014

IMedia Connection

5 brands that climbed out of reputation hell

For a brand, recovering its reputation after a crisis can be a complicated business.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Fri Aug 15, 2014

BioSpace

National Institute for Clinical Excellence (NICE) And Johnson & Johnson Urged To End Zytiga Fiasco

Patient groups and academics have urged the National Institute for Health and Care Excellence and Johnson & Johnson unit Janssen to get back to the table following the former's rejection of Zytiga as a treatment for prostate cancer before chemotherapy.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Thu Aug 14, 2014

Seeking Alpha

Johnson & Johnson: Don't Miss The Pullback Opportunity

JNJ can comfortably grow its dividend per share by 6%-7% per annum over the next few years with both free cash flow and earnings payout levels being steady.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Wed Aug 13, 2014

ThinkProgress

Check Your Mental Health With Just A Press Of A Button

Philadelphia residents can now check their mental health in the grocery store, thanks to an interactive screening kiosk known as "Checkup and Checkout" that officials unveiled earlier this month.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Fri Aug 08, 2014

News Times

Hysterectomy tool creates cancer fears

About 600,000 hysterectomies are performed in the U.S. each year. Research suggests about 40% are done to remove presumably benign or noncancerous fibroids that are causing heavy bleeding, pelvic pressure or pain or other symptoms Power morcellators, like the one below, are used in this procedure, are under scrutiny.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Seeking Alpha

Johnson & Johnson: Where Did The Bears Go? I Will Stand Alone.

Johnson & Johnson has had a nice climb in price over the last several years. The company has strong operating margins, low interest expenses, and a solid return on equity.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, Startups

Thu Aug 07, 2014

Seeking Alpha

Johnson & Johnson's Power Morcellator Recall Could Result In Further Pullback

Johnson & Johnson recently withdrew three laparoscopic power morcellators due to a risk of spreading cancerous tissue, following FDA's warning in April.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Daily Kos

Dear Johnson & Johnson: Pay for Your Mistakes

Johnson & Johnson grabbed headlines this week for withdrawing from the market power morcellators, manufactured by subsidiary Ethicon, citing " uncertainty " about the "risk-benefit assessment" associated with the device's use.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, Startups

Adweek

UM Gets a New U.S. President

Insider Kasha Cacy today succeeds Sarah Personette as U.S. president, as Personette exits following maternity leave to become the head of global business marketing at Facebook.

Comment?

Related Topix: Marketing, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups

Tue Aug 05, 2014

Seeking Alpha

Johnson & Johnson: A Quality Dividend Company At Attractive Valuation

Johnson & Johnson is a dividend king which has paid dividends since 1944 and has managed to increase them for 52 years in a row.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Mon Aug 04, 2014

Outpatient Surgery Magazine

Johnson & Johnson Asks Customers to Return Morcellators

As the polarized debate regarding the safety and desirability of power morcellation in minimally invasive hysterectomies continues to rage, Johnson & Johnson, easily the largest manufacturer of laparoscopic morcellators, has announced that it's withdrawing the device from the market.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Seeking Alpha

Ken Fisher's Top Stock Picks

Fisher's 13F portfolio contains over 600 long equity positions, out of which 81 are new positions, and 262 positions have been increased during the quarter.

Comment?

Related Topix: Apple, Startups, General Electric, Financial Services, Aerospace-Defense, Emerging Technology, Search Engines, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment

Sun Aug 03, 2014

Star Tribune

Klobuchar looks into contact lens prices

U.S. Sen. Amy Klobuchar is seeking greater scrutiny of a decision by three of the four top U.S. contact lens makers to set price minimums for products.

Comment?

Related Topix: US News, US Senate, Democrat, US Politics, Amy Klobuchar, Johnson and Johnson, Johnson & Johnson, Biotech, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, OrthoClinical Diagnostics, Medical Equipment

Sat Aug 02, 2014

Milwaukee Journal-Sentinal

GM stock likely to rebound after firm addresses problem

Johnson & Johnson became the role model for putting consumers first, spending more than $100 million in the 1982 recall and relaunch of Tylenol.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Aria Systems, Startups

Fri Aug 01, 2014

Hispanic Business

Johnson & Johnson - 10-Q - Management's Discussion and Analysis of...

Currency fluctuations had a negative impact of 1.1% for the fiscal six months of 2014.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

The Jersey Journal

Man found dead near New Brunswick train station had belt around neck, police say

NEW BRUNSWICK - A 36-year-old man whose decomposed body was found near the city train station a week after he was reported missing apparently committed suicide near the station, according to a recently released police report.

Comment?

Related Topix: Suicide, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups

Thu Jul 31, 2014

PhysOrg Weblog

Johnson & Johnson pulls hysterectomy tool tied to cancer risk from market

The largest maker of a surgical tool that has shown an increased risk of spreading undetected cancers in women has said it will withdraw its device from the market.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, Startups, Johnson Controls

Wall Street Journal

Johnson & Johnson Partners with CircleUp for Early Look at Startups

CircleUp COO Rory Eakin and CEO Ryan Caldbeck with an array of products made by companies that raised equity funding on their site.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••